13F filer · CIK 895421 ↗
Morgan Stanley
You are looking at Q4 2025. See the latest, Q2 2026 →
Reported value
$1.67T
+1.4% on the quarter before
Positions
8,196
515 new · 476 sold out
Top 10
22.2%
of the value
Est. gain
+$17.05B
on stocks held all quarter
Est. return
+1.1%
on those stocks since Q3 2025
Positions as of Dec 31, 2025, from Morgan Stanley's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 32% of the reported value, each sized by its share, colored by what the fund did with it since Q3 2025. Striped tiles are options.
Largest buys
Since Q3 2025, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- ServiceNow~$2.68BAdded · 0.3% → 0.2%+17,514,679 shares
- Vanguard Tax-Managed Fds~$1.73BAdded · 0.2% → 0.3%+27,650,637 shares
- SPDR Series Trust~$1.33BAdded · 0.1% → 0.1%+16,607,351 shares
- Select Sector SPDR Tr~$1.27BAdded · 0.2% → 0.2%+8,818,215 shares
- Vanguard Bd Index Fds~$1.21BAdded · 0.5% → 0.6%+16,287,510 shares
- SPDR Gold Tr~$1.01BAdded · 0.2% → 0.3%+2,539,266 shares
- SPDR Series Trust~$847.2MAdded · 0.1% → 0.1%+7,939,766 shares
- Ishares Tr~$690.0MAdded · 0.4% → 0.5%+3,280,476 shares
- Medline Inc~$636.8MNew · 0.0% → 0.0%+15,162,060 shares
- Select Sector SPDR Tr~$632.0MAdded · 0.1% → 0.1%+14,135,733 shares
Largest sells
Since Q3 2025, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- SPDR S&P 500 ETF Tr~$7.73BCut · 1.6% → 1.2%−11,330,026 shares
- Invesco Qqq Tr~$5.23BCut · 0.9% → 0.6%−8,516,396 shares
- Accenture Plc Ireland~$1.21BCut · 0.2% → 0.1%−4,496,538 shares
- AMD~$1.08BCut · 0.3% → 0.3%−5,019,930 shares
- Vanguard Bd Index Fds~$634.1MCut · 0.2% → 0.1%−8,046,456 shares
- SPDR Dow Jones Indl Average~$601.3MCut · 0.1% → 0.1%−1,251,185 shares
- Ishares Tr~$581.7MCut · 0.2% → 0.1%−7,023,607 shares
- Unilever Plc~$571.6MSold out · 0.0% → 0.0%−9,642,607 shares
- MongoDB~$561.8MCut · 0.1% → 0.0%−1,338,682 shares
- Vanguard Index Fds~$552.9MCut · 0.9% → 0.9%−881,557 shares
Holdings
As of Dec 31, 2025. Changes are in shares against Sep 30, 2025, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AppleCOM · shares +0.6% · price +6.8% | 3.7% | $62.66B | +$3.95B | ||||||||
| NvidiaCOM · shares +0.2% · price −0.0% | 3.6% | $60.38B | −$25.8M | ||||||||
| MicrosoftCOM · shares +0.8% · price −6.6% | 3.5% | $58.62B | −$4.13B | ||||||||
| AlphabetCAP STK CL A · shares −0.1% · price +28.8% | 2.3% | $38.12B | +$8.51B | ||||||||
| AmazonCOM · shares −0.8% · price +5.1% | 2.2% | $37.30B | +$1.82B | ||||||||
| BroadcomCOM · shares −0.06% · price +4.9% | 1.5% | $25.25B | +$1.18B | ||||||||
| MetaCL A · shares +2.2% · price −10.1% | 1.5% | $24.79B | −$2.73B | ||||||||
| AlphabetCAP STK CL C · shares +1.6% · price +28.8% | 1.3% | $22.54B | +$4.97B | ||||||||
| Jpmorgan Chase & Co.COM · shares +1.4% · price +2.2% | 1.3% | $21.39B | +$444.4M | ||||||||
| SPDR S&P 500 ETF TrTR UNIT · shares −28% · price +2.4% | 1.2% | $20.00B | +$461.6M | ||||||||
| Eli LillyCOM · shares +2.7% · price +40.8% | 1.0% | $16.76B | +$4.73B | ||||||||
| Ishares TrCORE S&P500 ETF · shares −1.2% · price +2.3% | 0.98% | $16.46B | +$375.8M | ||||||||
| Visa Inc.COM CL A · shares −2.5% · price +2.7% | 0.98% | $16.44B | +$437.2M | ||||||||
| TeslaCOM · shares −1.0% · price +1.1% | 0.96% | $16.09B | +$178.9M | ||||||||
| Vanguard Index FdsS&P 500 ETF SHS · shares −3.5% · price +2.4% | 0.92% | $15.41B | +$362.4M | ||||||||
| Berkshire Hathaway Inc DelCL B NEW · shares −1.1% · price −0.0% | 0.79% | $13.21B | −$2.4M | ||||||||
| Ishares TrRUS 1000 GRW ETF · shares +2.2% · price +1.0% | 0.78% | $13.08B | +$132.3M | ||||||||
| Invesco Qqq TrUNIT SER 1 · shares −35% · price +2.3% | 0.59% | $9.85B | +$223.6M | ||||||||
| Johnson & JohnsonCOM · shares −4.0% · price +11.6% | 0.57% | $9.59B | +$997.4M | ||||||||
| Walmart IncCOM · shares −1.2% · price +8.1% | 0.56% | $9.39B | +$703.7M | ||||||||
| Ishares TrCORE MSCI EAFE · shares +4.9% · price +2.5% | 0.56% | $9.38B | +$215.0M | ||||||||
| Vanguard Bd Index FdsTOTAL BND MRKT · shares +15% · price −0.4% | 0.55% | $9.25B | −$32.6M | ||||||||
| MastercardCL A · shares +0.8% · price +0.4% | 0.55% | $9.16B | +$33.0M | ||||||||
| Abbvie IncCOM · shares −3.9% · price −1.3% | 0.55% | $9.15B | −$122.1M | ||||||||
| Exxon Mobil CorpCOM · shares −0.6% · price +6.7% | 0.53% | $8.96B | +$565.1M | ||||||||
| Total · 8,196 positions | 100% | $1.67T | +$17.05B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q3 2025 to Q4 2025: 7,506 stocks held throughout, up $17.05B (+1.1%).
- Alphabet+$8.51B+29%
- Alphabet+$4.97B+29%
- Eli Lilly+$4.73B+41%
- Apple+$3.95B+7%
- Micron+$1.84B+71%
- Netflix10:1 split−$2.22B−22%
- Oracle−$2.30B−31%
- Meta−$2.73B−10%
- ServiceNow−$4.00B−83%
- Microsoft−$4.13B−7%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 58 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 13, 2026 | $1.89T+14% | SEC ↗ |
| Q1 2026 | May 15, 2026 | $1.66T−1% | SEC ↗ |
| Q4 2025 | May 27, 2026 (amended) | $1.67T+1% | SEC ↗ |
| Q3 2025 | May 27, 2026 (amended) | $1.65T+8% | SEC ↗ |
| Q2 2025 | Aug 15, 2025 | $1.54T+10% | SEC ↗ |
| Q1 2025 | May 15, 2025 | $1.40T−2% | SEC ↗ |
| Q4 2024 | May 15, 2025 (amended) | $1.43T+3% | SEC ↗ |
| Q3 2024 | May 14, 2025 (amended) | $1.38T+7% | SEC ↗ |
| Q2 2024 | May 14, 2025 (amended) | $1.29T−65% | SEC ↗ |
| Q1 2024 | May 15, 2024 (amended) | $3.74T+65% | SEC ↗ |
| Q4 2023 | Feb 13, 2024 (amended) | $2.27T+131% | SEC ↗ |
| Q3 2023 | Nov 15, 2023 | $983.41B−3% | SEC ↗ |
| Q2 2023 | Aug 14, 2023 | $1.01T+9% | SEC ↗ |
| Q1 2023 | May 15, 2023 | $932.64B+6% | SEC ↗ |
| Q4 2022 | Feb 14, 2023 | $880.47B+20% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $733.72B−5% | SEC ↗ |
| Q2 2022 | Oct 27, 2022 (amended) | $770.42B+4% | SEC ↗ |
| Q1 2022 | Oct 27, 2022 (amended) | $741.46B−8% | SEC ↗ |
| Q4 2021 | Feb 14, 2022 | $809.87B+9% | SEC ↗ |
| Q3 2021 | Nov 15, 2021 | $742.48B−2% | SEC ↗ |
| Q2 2021 | Aug 23, 2021 (amended) | $758.13B+11% | SEC ↗ |
| Q1 2021 | May 17, 2021 | $680.76B+5% | SEC ↗ |
| Q4 2020 | Feb 16, 2021 | $647.47B+25% | SEC ↗ |
| Q3 2020 | Nov 13, 2020 | $517.01B+14% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $451.78B+23% | SEC ↗ |
| Q1 2020 | May 26, 2020 (amended) | $367.99B−14% | SEC ↗ |
| Q4 2019 | Feb 14, 2020 | $430.00B+14% | SEC ↗ |
| Q3 2019 | Nov 14, 2019 | $377.76B+1% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $375.74B+6% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $353.27B+6% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $334.17B−16% | SEC ↗ |
| Q3 2018 | Apr 23, 2019 (amended) | $399.53B+8% | SEC ↗ |
| Q2 2018 | Apr 23, 2019 (amended) | $370.13B+3% | SEC ↗ |
| Q1 2018 | Apr 23, 2019 (amended) | $360.30B−1% | SEC ↗ |
| Q4 2017 | Apr 23, 2019 (amended) | $365.35B+9% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $333.86B+1% | SEC ↗ |
| Q2 2017 | Aug 11, 2017 | $331.01B−49% | SEC ↗ |
| Q1 2017 | May 12, 2017 (amended) | $651.13B+7% | SEC ↗ |
| Q4 2016 | Feb 13, 2017 (amended) | $611.12B+109% | SEC ↗ |
| Q3 2016 | Nov 10, 2016 | $292.79B+6% | SEC ↗ |
| Q2 2016 | Aug 12, 2016 | $276.85B+7% | SEC ↗ |
| Q1 2016 | May 12, 2016 | $259.85B | SEC ↗ |